Ms Gidley spoke to C+D at a Royal Pharmaceutical Society (RPS) event on electronic records access at Portcullis House in London on Wednesday (January 6).
Alongside her criticism of the General Pharmaceutical Council's (GPhC) handling of the Pharmacy2U data-selling scandal, Ms Gidley raised concerns about how the company's activities could undermine trust in the sector.
The GPhC stressed to C+D that it "is continuing to take forward its case in relation to the misuse of patient information by Pharmacy2U". "It is our policy to not provide further details of the case while it is ongoing,” it said today (January 8).
A GPhC inspection of the business in May 2015 had found "no other immediate patient safety concerns", it added.